semaglutide approval for mash 🎉Exciting news that is now FDA approved (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Live Updates on Semaglutide's Current

The clinical relevance of hOAT-3 in sitagliptin transport has not been established

These findings underscore the immense potential of this therapeutic approach for individuals struggling with obesity

Upon its release by Novo Nordisk in early 2026, oral semaglutide became the first oral GLP-1 approved specifically for weight loss

Long-term Expectations For most people, the side effect phase is temporary

GLP-1 and weight loss are constantly in the news, and everyone is talking about these drugs like Ozempic, Wegovy, and related GLP-1 formulations like semaglutide, she says

Unfortunately, if were not conscious of what is going on, the food sought out tends to be another sugar bomb that restarts the cycle